Researchers at the University of Michigan in the US have designed novel vaccine nanodiscs that could be used to treat cancer. The lipoprotein-mimicking nanostructures coupled with antigen peptides and adjuvants efficiently deliver vaccine components to lymphoid tissues and so are significantly better than conventional vaccines in this context. They could herald a new era of personalized cancer immunotherapy if used with patient-specific tumour antigens……..
http://nanotechweb.org/cws/article/tech/67463
